{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:03:35Z","timestamp":1788260615215,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Center in Poland","award":["2017\/25\/N\/NZ5\/02595"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02595"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05974-5","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:07:49Z","timestamp":1757416069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum levels of PECAM-1, ICAM-1, and VCAM-1 in patients with systemic lupus erythematosus: associations with disease activity and clinical features from a single-center study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4094-5961","authenticated-orcid":false,"given":"Gabriela","family":"Rybka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-5436","authenticated-orcid":false,"given":"Kazimierz","family":"W\u0119glarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-5412","authenticated-orcid":false,"given":"Maciej","family":"Siedlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-2253","authenticated-orcid":false,"given":"Joanna","family":"Kosa\u0142ka-W\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"5974_CR1","doi-asserted-by":"publisher","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L (May 2024) Systemic lupus erythematosus. Lancet 403(10441):2326\u20132338. https:\/\/doi.org\/10.1016\/S0140-6736(24)00398-2","DOI":"10.1016\/S0140-6736(24)00398-2"},{"key":"5974_CR2","doi-asserted-by":"publisher","unstructured":"Siegel CH, Sammaritano LR (May 2024) Systemic lupus erythematosus: a review. JAMA 331:1480. https:\/\/doi.org\/10.1001\/jama.2024.2315","DOI":"10.1001\/jama.2024.2315"},{"key":"5974_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30330","author":"MA Ameer","year":"2022","unstructured":"Ameer MA et al (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus Oct. https:\/\/doi.org\/10.7759\/cureus.30330","journal-title":"Cureus Oct"},{"key":"5974_CR4","doi-asserted-by":"publisher","unstructured":"Fanouriakis A et al (Jan. 2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","DOI":"10.1136\/ard-2023-224762"},{"key":"5974_CR5","doi-asserted-by":"publisher","unstructured":"Mak A, Chan JKY (May 2022) Endothelial function and endothelial progenitor cells in systemic lupus erythematosus. Nat Rev Rheumatol 18(5):286\u2013300. https:\/\/doi.org\/10.1038\/s41584-022-00770-y","DOI":"10.1038\/s41584-022-00770-y"},{"key":"5974_CR6","doi-asserted-by":"publisher","unstructured":"Grover-P\u00e1ez F, Zavalza-G\u00f3mez AB (2009) Endothelial dysfunction and cardiovascular risk factors, Diabetes Res Clin Practice, 84(1): 1\u201310. https:\/\/doi.org\/10.1016\/j.diabres.2008.12.013","DOI":"10.1016\/j.diabres.2008.12.013"},{"key":"5974_CR7","doi-asserted-by":"publisher","unstructured":"Sciatti E et al (2019) Systemic Lupus Erythematosus and endothelial dysfunction: a close relationship, CRR, 15(3): 177\u2013188. https:\/\/doi.org\/10.2174\/1573397115666181126105318","DOI":"10.2174\/1573397115666181126105318"},{"key":"5974_CR8","doi-asserted-by":"publisher","unstructured":"Ambler WG, Kaplan MJ (2024) Vascular damage in systemic lupus erythematosus, Nat Rev Nephrol, 20(4): 251\u2013265. https:\/\/doi.org\/10.1038\/s41581-023-00797-8","DOI":"10.1038\/s41581-023-00797-8"},{"key":"5974_CR9","doi-asserted-by":"publisher","unstructured":"Moschetti L et al (Apr. 2022) Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: a common trigger for different microvascular diseases. Front Med 9:849086. https:\/\/doi.org\/10.3389\/fmed.2022.849086","DOI":"10.3389\/fmed.2022.849086"},{"key":"5974_CR10","doi-asserted-by":"publisher","unstructured":"Mendoza-Pinto C et al (Mar. 2020) Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Atherosclerosis 297:55\u201363. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.01.028","DOI":"10.1016\/j.atherosclerosis.2020.01.028"},{"key":"5974_CR11","doi-asserted-by":"publisher","unstructured":"Nowak K, Gumkowska-Sroka O, Kotyla P (2022) Adhesion molecules: a way to understand lupus, Reumatologia, 60(2): 133\u2013141. https:\/\/doi.org\/10.5114\/reum.2022.115664","DOI":"10.5114\/reum.2022.115664"},{"key":"5974_CR12","doi-asserted-by":"publisher","unstructured":"McMurray RW (1996) Adhesion molecules in autoimmune disease, Seminars in Arthritis and Rheumatism. 25(4): 215\u2013233. https:\/\/doi.org\/10.1016\/S0049-0172(96)80034-5","DOI":"10.1016\/S0049-0172(96)80034-5"},{"key":"5974_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/1270","volume":"9","author":"L Horstman","year":"2004","unstructured":"Horstman L (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9:1\u20133. https:\/\/doi.org\/10.2741\/1270","journal-title":"Front Biosci"},{"key":"5974_CR14","doi-asserted-by":"publisher","unstructured":"Blankenberg S, Barbaux S, Tiret L (Oct. 2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191\u2013203. https:\/\/doi.org\/10.1016\/S0021-9150(03)00097-2","DOI":"10.1016\/S0021-9150(03)00097-2"},{"key":"5974_CR15","doi-asserted-by":"publisher","unstructured":"L. F. Da Rosa Franchi Santos et al. (2018) Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels, Lupus, 27(3): 380\u2013388. https:\/\/doi.org\/10.1177\/0961203317723716","DOI":"10.1177\/0961203317723716"},{"key":"5974_CR16","doi-asserted-by":"publisher","unstructured":"Bui TM, Wiesolek HL, Sumagin R (2020) ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis, J Leukocyte Biol 108(3): 787\u2013799. https:\/\/doi.org\/10.1002\/JLB.2MR0220-549R","DOI":"10.1002\/JLB.2MR0220-549R"},{"key":"5974_CR17","unstructured":"Cotran RS, Mayadas-Norton T (1998) Endothelial adhesion molecules in health and disease, Pathol Biol (Paris), 46(3): 164\u2013170"},{"key":"5974_CR18","first-page":"1","volume":"118","author":"P Cie\u015blik","year":"2008","unstructured":"Cie\u015blik P, Hrycek A, K\u0142uci\u0144ski P (2008) Vasculopathy and vasculitis in systemic lupus erythematosus. Pol Arch Med Wewn 118:1\u20132","journal-title":"Pol Arch Med Wewn"},{"key":"5974_CR19","doi-asserted-by":"publisher","unstructured":"Aringer M (2019) EULAR\/ACR classification criteria for SLE, Seminars in Arthritis and Rheumatism, 49(3): S14\u2013S17. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009","DOI":"10.1016\/j.semarthrit.2019.09.009"},{"key":"5974_CR20","doi-asserted-by":"publisher","unstructured":"Kaczmarczyk K, Kosalka J, Soja J, Kuzniewski M, Musial J, Okon K (2014) Renal interstitial mast cell counts differ across classes of proliferative lupus nephritis, Folia Histochem Cytobiol. 52(3): 218\u2013224. https:\/\/doi.org\/10.5603\/FHC.2014.0025","DOI":"10.5603\/FHC.2014.0025"},{"key":"5974_CR21","doi-asserted-by":"publisher","unstructured":"Szymanik-Grzelak H et al (2021) Retrospective analysis of clinical and pathomorphological features of lupus nephritis in children, Adv Med Sci 66(1): 128\u2013137. https:\/\/doi.org\/10.1016\/j.advms.2021.01.004","DOI":"10.1016\/j.advms.2021.01.004"},{"key":"5974_CR22","doi-asserted-by":"publisher","unstructured":"Jakiela B et al (2018) Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis, Lupus. 27(8): 1259\u20131270. https:\/\/doi.org\/10.1177\/0961203318770006","DOI":"10.1177\/0961203318770006"},{"key":"5974_CR23","doi-asserted-by":"publisher","unstructured":"Aljaberi N et al (May 2022) Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus. Lupus Sci Med 9(1):e000631. https:\/\/doi.org\/10.1136\/lupus-2021-000631","DOI":"10.1136\/lupus-2021-000631"},{"key":"5974_CR24","doi-asserted-by":"publisher","unstructured":"Lisnevskaia L, Murphy G, Isenberg D (Nov. 2014) Systemic lupus erythematosus. Lancet 384(9957):1878\u20131888. https:\/\/doi.org\/10.1016\/S0140-6736(14)60128-8","DOI":"10.1016\/S0140-6736(14)60128-8"},{"key":"5974_CR25","doi-asserted-by":"publisher","unstructured":"Pons-Estel GJ, Alarc\u00f3n GS, Scofield L, Reinlib L, Cooper GS (2010) Understanding the epidemiology and progression of systemic Lupus Erythematosus, Seminars in Arthritis and Rheumatism, 39(4): 257\u2013268. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.10.007","DOI":"10.1016\/j.semarthrit.2008.10.007"},{"key":"5974_CR26","doi-asserted-by":"publisher","unstructured":"Yu KY et al (2021) Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis, Lupus. 30(7): 1039\u20131050. https:\/\/doi.org\/10.1177\/09612033211004727","DOI":"10.1177\/09612033211004727"},{"key":"5974_CR27","doi-asserted-by":"publisher","unstructured":"Soliman SA, Stanley S, Vanarsa K, Ismail F, Mok CC, Mohan C (Aug. 2022) Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis. Front Immunol 13:910993. https:\/\/doi.org\/10.3389\/fimmu.2022.910993","DOI":"10.3389\/fimmu.2022.910993"},{"key":"5974_CR28","doi-asserted-by":"crossref","unstructured":"Bergkamp SC et al (Sep. 2024) Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus. Lupus Sci Med 11:e001190. no. 210.1136\/lupus-2024-001190","DOI":"10.1136\/lupus-2024-001190"},{"key":"5974_CR29","doi-asserted-by":"publisher","unstructured":"Bergkamp SC et al (May 2023) Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis. J Inflamm 20(1):18. https:\/\/doi.org\/10.1186\/s12950-023-00342-1","DOI":"10.1186\/s12950-023-00342-1"},{"key":"5974_CR30","doi-asserted-by":"publisher","unstructured":"Mahayidin H, Yahya NK, Wan Ghazali WS, Mohd Ismail A, Wan Ab Hamid WZ (2014) The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity, Int Scholarly Res Notices pp 1\u20136, 2014. https:\/\/doi.org\/10.1155\/2014\/275194","DOI":"10.1155\/2014\/275194"},{"key":"5974_CR31","doi-asserted-by":"publisher","unstructured":"Cie\u015blik P, Semik-Grabarczyk E, Hrycek A, Holecki M (May 2022) The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study. Rheumatol Int 42(5):791\u2013801. https:\/\/doi.org\/10.1007\/s00296-022-05104-5","DOI":"10.1007\/s00296-022-05104-5"},{"key":"5974_CR32","doi-asserted-by":"publisher","unstructured":"Ahmadi B, Bonakdar ZS, Hashemi SM, Sadrkabir SM, Karimifar M (Jan. 2011) Endothelial dysfunction in Iranian lupus patients. Rheumatol Int 31(1):27\u201331. https:\/\/doi.org\/10.1007\/s00296-009-1212-0","DOI":"10.1007\/s00296-009-1212-0"},{"key":"5974_CR33","doi-asserted-by":"publisher","unstructured":"Guo Liu R-N, Cheng Q-Y, Zhou H-Y, Li B-Z, Ye D-Q (Feb. 2020) Elevated blood and urinary ICAM-1 is a biomarker for systemic lupus erythematosus: a systematic review and meta-analysis. Immunol Investig 49:1\u20132. https:\/\/doi.org\/10.1080\/08820139.2019.1624769","DOI":"10.1080\/08820139.2019.1624769"},{"issue":"1","key":"5974_CR34","first-page":"5","volume":"12","author":"PP Sfikakis","year":"1994","unstructured":"Sfikakis PP, Charalambopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos GC (1994) Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 12(1):5\u20139","journal-title":"Clin Exp Rheumatol"},{"key":"5974_CR35","doi-asserted-by":"publisher","unstructured":"Sari R et al (Jan. 2002) Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus. Rheumatol Int 21(4):149\u2013152. https:\/\/doi.org\/10.1007\/s00296-001-0159-6","DOI":"10.1007\/s00296-001-0159-6"},{"key":"5974_CR36","doi-asserted-by":"publisher","unstructured":"Sabry A, Sheashaa H, El-Husseini A, El-Dahshan K, Abdel-Rahim M, Elbasyouni SR (2007) Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis, Clin Rheumatol, 26(11): 1819\u20131823. https:\/\/doi.org\/10.1007\/s10067-007-0580-7","DOI":"10.1007\/s10067-007-0580-7"},{"key":"5974_CR37","doi-asserted-by":"publisher","unstructured":"Pamuk ON et al (2014) PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events? Clin Rheumatol. 33(12): 1737\u20131743. https:\/\/doi.org\/10.1007\/s10067-014-2771-3","DOI":"10.1007\/s10067-014-2771-3"},{"key":"5974_CR38","doi-asserted-by":"publisher","unstructured":"Papachristodoulou E, Kakoullis L, Christophi C, Psarelis S, Hajiroussos V, Parperis K (2023) The relationship of neutrophil-to-lymphocyte ratio with health-related quality of life, depression, and disease activity in SLE: a cross-sectional study, Rheumatol Int. 43(10): 1841\u20131848. https:\/\/doi.org\/10.1007\/s00296-023-05381-8","DOI":"10.1007\/s00296-023-05381-8"},{"key":"5974_CR39","doi-asserted-by":"publisher","unstructured":"on behalf of the FHU ACRONIM (Dec. 2017) Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review. Arthritis Res Ther 19(1):238. https:\/\/doi.org\/10.1186\/s13075-017-1442-6","DOI":"10.1186\/s13075-017-1442-6"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05974-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:14:51Z","timestamp":1760523291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05974-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["5974"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05974-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"223"}}